Pharmspective Launches Affordable Care Act Knowledge And News Hub For Healthcare Decision-Makers
NEW YORK, Nov. 27, 2012 /PRNewswire/ -- Pharmspective, LLC announced the launch today of HealthcareReformInsider.com, a knowledge and news hub for key stakeholders impacted by the Affordable Care Act (ACA). HealthcareReformInsider.com will aggregate news, research, policy analysis, and government directives on the ACA for key decision makers assessing upcoming strategic choices driven by implementation of the ACA. Pharmspective provide market research and knowledge management applications to the pharmaceutical industry.
"We set out to simplify the acquisition of Healthcare Reform information for key decision makers when we designed HealthcareReformInsider.com," stated Katie Derdeyn, M.D., Managing Partner & Co-Founder of Pharmspective. "There is a real need for an information portal that vets everything that's written about the ACA and extracts what's relevant for building strategies for leading healthcare organizations. HealthcareReformInsider.com will do that and ensure that its users are up-to-date on the latest key developments involving the Affordable Care Act."
By honing in on the emerging and evolving insurer entities (State Exchanges, Medicaid, and Medicare) that will drive expansion of coverage, the new healthcare models that will drive changes in how care is provided (ACOs, Community Health Centers, Medical Homes, etc.), and the regulations that will influence payment (MLR rules, Individual Mandate, Quality-based Incentives, etc.), HealthcareReformInsider.com provides a destination for knowledge acquisition related to this expansive legislation.
"Our experience in helping healthcare organizations understand the ACA has allowed us to construct a site that provides the most relevant and current ACA news and policy analysis," said Stephen Reid, Managing Partner and leader of Pharmspective's Healthcare Reform practice. "Following HealthcareReformInsider.com on the web and on Twitter (@hcrinsider) will keep healthcare decision-makers informed on the latest ACA developments that impact their market strategies."About Pharmspective: Pharmspective, LLC (pharmspective.com) is a Specialty Therapeutics Market Research firm providing commercial insights and knowledge management applications for the biopharmaceutical industry. The company is uniquely focused on understanding the buying process for specialty therapeutics through syndicated market research studies examining clinical decision-making, drug acquisition, access and reimbursement, and therapy administration for specialty therapeutics in autoimmune diseases and Oncology. Pharmspective's Healthcare Reform team provides insights into the Affordable Care Act through its proprietary ClearView knowledge management application, market assessments of the impact of key ACA provisions on healthcare decision-makers, and its HealthCareReformInsider.com website. The company maintains offices in New York City and St. Louis, MO. Follow Pharmspective on Twitter at twitter.com/Pharmspective and follow HealthcareReformInsider.com on Twitter at twitter.com/hcrinsider. Contact: Cindy Wong Tel: 314-814-2729 x1003 cindy.wong@Pharmspective.com. SOURCE Pharmspective, LLC
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV